# Adamant Health

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/adamant-health

- Industry: Medical Devices & Equipment
- Headquarters: Helsinki, Finland
- Website: www.adamanthealth.com
- Total disclosed funding: $2.3M
- Latest round: Seed (Jun 13, 2022)
- Investors on record: 3

## About

Based in Helsinki, Finland, and founded in 2020, Adamant Health Oy is a spin-off from the University of Eastern Finland that operates as a MedTech firm to analyze Parkinson's disease symptoms. The company was founded by its CEO, Paulus Carpelan, and CTO, Saara Rissanen. In June 2022, Adamant Health Oy raised EUR 2.2 million in seed funding from Gerresheimer AG, COR Group, and Voima Ventures.

Adamant Health offers a Parkinson’s disease measurement and analysis service platform that uses a wearable device that combines electromyography (EMG) and motion sensors to collect data on Parkinson's disease symptoms. The data is then analyzed by healthcare providers to provide insights into the impact of medication on symptoms and help pharmaceutical companies develop new medicines for Parkinson’s disease. The company gathers information from people who have movement disorders, offers in-depth visibility of the patient's motor symptoms, and employs technology to monitor and treat the symptoms of movement disorders by employing neuromuscular signals.

## Funding rounds

- Seed, Jun 13, 2022, $2.3M — Gerresheimer AG, Voima Ventures, COR Group

## Investors

- Gerresheimer AG — Seed
- Voima Ventures (https://capitalatlas.ai/funds/voima-ventures) — Seed
- COR Group (https://capitalatlas.ai/funds/cor-group) — Seed